NYSE · Medical - Healthcare Information Services
TDOC (TDOC) Stock
$6.58
-28.32%
NYSE: TDOC
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Teladoc (TDOC) Gains As Market Dips: What You Should Know
Zacks · Jul 20, 2026
Teladoc Health to Announce Second Quarter 2026 Financial Results
GlobeNewswire · Jul 15, 2026
3 Unpopular Stocks We Steer Clear Of
StockStory · Jul 15, 2026
3 Russell 2000 Stocks with Open Questions
StockStory · Jul 13, 2026
2 Momentum Stocks with Promising Prospects and 1 We Ignore
StockStory · Jul 10, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.69%
Institutions Held83.69%
Institutions Float Held84.27%
Peer Comparison
About TDOC
TDOC is led by CEO Charles Divita, employs 4,620 people, headquartered in US, publicly traded since 2015.
TDOC stock trades at $6.58 with a market capitalization of $1.19B. The stock is valued at a price-to-earnings (P/E) ratio of -11.81, price-to-book of 1.03, price-to-sales of 0.55. Over the past 52 weeks the stock has ranged between $4.40 and $9.84, and currently trades 33.1% below its 52-week high.
On profitability, TDOC generates a return on equity (ROE) of -12.39%, return on capital employed of -18.98%, an operating margin of -7.60%, a net profit margin of -6.81%.